1 |
Bekele BB, Bogale B, Negash S, Tesfaye M, Getachew D, Weldekidan F, Yosef T. Public health interventions on prescription redemptions and secondary medication adherence among type 2 diabetes patients: systematic review and meta-analysis of randomized controlled trials. J Diabetes Metab Disord 2021;20:1933-56. [PMID: 34900834 DOI: 10.1007/s40200-021-00878-0] [Reference Citation Analysis]
|
2 |
Ferns G. Cause, consequence or coincidence: The relationship between psychiatric disease and metabolic syndrome. Translational Metabolic Syndrome Research 2018;1:23-38. [DOI: 10.1016/j.tmsr.2018.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
3 |
Lee J, Dalack GW, Casher MI, Eappen SA, Bostwick JR. Persistence of metabolic monitoring for psychiatry inpatients treated with second-generation antipsychotics utilizing a computer-based intervention. J Clin Pharm Ther 2016;41:209-13. [PMID: 26919449 DOI: 10.1111/jcpt.12368] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
4 |
Richly P, López P, Gleichgerrcht E, Flichtentrei D, Prats M, Mastandueno R, Bustin J, Cetkovich-Bakmas M. Psychiatrists’ approach to vascular risk assessment in Latin America. World J Psychiatr 2014; 4(3): 56-61 [PMID: 25250222 DOI: 10.5498/wjp.v4.i3.56] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
5 |
Ventriglio A, Gentile A, Baldessarini RJ, Martone S, Vitrani G, La Marca A, Bellomo A. Improvements in metabolic abnormalities among overweight schizophrenia and bipolar disorder patients. Eur Psychiatry 2014;29:402-7. [PMID: 24439513 DOI: 10.1016/j.eurpsy.2013.11.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|